Cargando…

PD-L1 testing, fit for routine evaluation? From a pathologist’s point of view

Tumours with high somatic mutation rates escape immune surveillance by upregulating receptors and ligands such as programmed death receptor-1 and its ligand (PD-1/PD-L1). Checkpoint inhibitors (ICI) provide encouraging therapeutic results in non-small cell lung cancers (NSCLC) and may soon be used i...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hutarew, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2016
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165031/ https://www.ncbi.nlm.nih.gov/pubmed/28058063 http://dx.doi.org/10.1007/s12254-016-0292-2

Ejemplares similares

Novel Synthetic Opioids: The Pathologist’s Point of View
por: Frisoni, Paolo, et al.
Publicado: (2018)

SARS-CoV-2 and Skin: The Pathologist’s Point of View
por: Cazzato, Gerardo, et al.
Publicado: (2021)

Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View
por: Mazzucchelli, Roberta, et al.
Publicado: (2021)

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)
por: Cheung, Carol C., et al.
Publicado: (2019)

Pediatric vascular tumors of the liver: Review from the pathologist’s point of view
por: Cordier, Fleur, et al.
Publicado: (2021)

The correct methodological approach to the diagnosis of celiac disease: the point of view of the pathologist
por: Villanacci, Vincenzo, et al.
Publicado: (2023)

Endometrium at Menopause: The Pathologist's View
por: Swain, Meenakshi, et al.
Publicado: (2021)

PD−L1 immunostaining: what pathologists need to know
por: Akhtar, Mohammed, et al.
Publicado: (2021)

Over view for the truth of COVID -19 pandemic: A guide for the Pathologists, Health care workers and community’
por: Bukhari, Mulazim Hussain, et al.
Publicado: (2020)

Correction: PD − L1 immunostaining: what pathologists need to know
por: Akhtar, Mohammed, et al.
Publicado: (2022)

Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View
por: Wu, Chiao-En, et al.
Publicado: (2019)

Sentinel Lymph Node in Breast Cancer: Review Article from a Pathologist’s Point of View
por: Apple, Sophia K.
Publicado: (2016)

Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
por: Marletta, Stefano, et al.
Publicado: (2022)

Pathologist’s perspectives on reporting of tumour budding in colorectal cancer
por: Roya, Paromita, et al.
Publicado: (2021)

The novel 19G endobronchial USS (EBUS) needle samples processed as tissue “core biopsies” facilitate PD‐L1 and other biomarker testing in lung cancer specimens: case report and the view point from the Respiratory Physician and the Pathologist
por: Herath, Samantha, et al.
Publicado: (2017)

Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspective
por: Malapelle, Umberto, et al.
Publicado: (2012)

Comparing outcomes: The Clinical Outcome in Routine Evaluation from an international point of view
por: Zeldovich, Marina, et al.
Publicado: (2019)

Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists
por: Brcic, Luka, et al.
Publicado: (2020)

COVID-19: Brief check through the pathologist's eye (autopsy archive)
por: Mansueto, Gelsomina
Publicado: (2020)

A GIST or not a GIST? That is the question
por: Chrysanthos, Nikolaos, et al.
Publicado: (2014)

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade
por: Huemer, Florian, et al.
Publicado: (2019)

Telocytes are the common cell of origin of both PEComas and GISTs: an evidence-supported hypothesis
por: Ardeleanu, Carmen, et al.
Publicado: (2011)

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group
por: Perrier, Lionel, et al.
Publicado: (2018)

Oncologist’s/haematologist’s view on the roles of pathologists for molecular targeted cancer therapy
por: Keller, Ulrich, et al.
Publicado: (2010)

Perspectives of Speech-Language Pathologists on the Use of Telepractice in Schools: The Qualitative View
por: Tucker, Janice K.
Publicado: (2012)

An analysis of pathologists’ viewing processes as they diagnose whole slide digital images
por: Ghezloo, Fatemeh, et al.
Publicado: (2022)

Camouflaging in Developmental Language Disorder: The Views of Speech and Language Pathologists and Parents
por: Hobson, Hannah M., et al.
Publicado: (2022)

The Challenge to the Pathologist of PD-L1 Expression in Tumor Cells of Non-Small-Cell Lung Cancer—An Overview
por: Jöhrens, Korinna, et al.
Publicado: (2021)

Synchronous double gastric tumors: GIST or not GIST
por: Sayida, Sa’d, et al.
Publicado: (2020)

Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure
por: Bins, Sander, et al.
Publicado: (2016)

Economics of Genetics from a Health Commissioning Point of View
por: Turner, Richard D.
Publicado: (1999)

The challenge of prognostic markers in acute pancreatitis: internist’s point of view
por: Para, Ombretta, et al.
Publicado: (2021)

What’s the Mass? The Gist of Point-of-care Ultrasound in Gastrointestinal Stromal Tumors
por: Chan, Kim P.
Publicado: (2018)

BDNF expression in GISTs predicts poor prognosis when associated with PD-L1 positive tumor-infiltrating lymphocytes
por: Tian, Guang-Ang, et al.
Publicado: (2021)

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study
por: Lang, David, et al.
Publicado: (2019)

Community‐driven demand creation for the use of routine viral load testing: a model to scale up routine viral load testing
por: Killingo, Bactrin M, et al.
Publicado: (2017)

Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist’s microscope
por: Aparicio, Samuel, et al.
Publicado: (2014)

Histopathological Analysis of 173 Consecutive Patients with Colorectal Carcinoma: A Pathologist’s View
por: Göret, Ceren Canbey, et al.
Publicado: (2018)

A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies
por: Bu, Melissa T., et al.
Publicado: (2022)

Methylome Profiling of PD-L1-Expressing Glioblastomas Shows Enrichment of Post-Transcriptional and RNA-Associated Gene Regulation
por: Hutarew, Georg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ro9fcc1jhunnt9bg6p66snti2h